1Novel MEFV transcripts in Familial Mediterranean fever patients and controls

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Medlej Hashim, Myrna ^a,b   Nehme, Nancy ^a   Chouery, Eliane ^a   Jalkh, Nadine ^a   Megarbane, André ^a  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b LEBANESE UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MEFV; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; DIAGNOSTIC AGENT; MARENOSTRIN; PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FAMILIAL MEDITERRANEAN FEVER; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; HETEROZYGOSITY; HUMAN; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA SPLICING; TRANSCRIPTION REGULATION; ARAB; ETHNIC GROUP; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOTE; JEW; MUTATION; PHENOTYPE;

ARABS; CYTOSKELETAL PROTEINS; ETHNIC GROUPS; EXONS; FAMILIAL MEDITERRANEAN FEVER; GENE EXPRESSION REGULATION; HETEROZYGOTE; HUMANS; JEWS; MUTATION; PHENOTYPE; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77953224474     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-87     Document Type: Article

References (21)

1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean Fever. A survey of 470 cases and review of the literature. Am J Med 1967, 43:227-253. 10.1016/0002-9343(67)90167-2, 5340644.
2. The French FMF Consortium A candidate gene for familial Mediterranean fever. Nat Genet 1997, 17:25-31. 10.1038/ng0997-25, 9288094, The French FMF Consortium.
3. The International FMF Consortium Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997, 90:797-807. 10.1016/S0092-8674(00)80539-5, 9288758, The International FMF Consortium.
4. Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I, Lesage S, Waterham H, Wise C, Sarrauste de Menthiere C, Touitou I. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat 2008, 29(6):803-808. 10.1002/humu.20720, 18409191.
5. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001, 9:473-483. 10.1038/sj.ejhg.5200658, 11464238.
6. Gumucio DL, Diaz A, Schaner P, Richards N, Babcock C, Schaller M, Cesena T. Fire and ice: The role of pyrin domain-containing proteins in inflammation and apoptosis. Clin Exp Rheumatol 2002, 20(4 Suppl 26):S45-S53.
7. Centola M, Aksentijevich I, Kastner DL. The hereditary periodic fever syndromes: molecular analysis of a new family of inflammatory diseases. Hum Mol Genet 1998, 7(10):1581-1588. 10.1093/hmg/7.10.1581, 9735379.
8. Martinon F, Hoffman K, Tschopp J. The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr Biol 2001, 10:R118-R120.
9. Centola M, Wood G, Frucht DM, Galon J, Aringer M, Farrell C, Kingma DW, Horwitz ME, Mansfield E, Holland SM, O'Shea JJ, Rosenberg HF, Malech HL, Kastner DL. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000, 95(10):3223-3231.
10. Tidow N, Chen X, Müller C, Kawano S, Gombart AF, Fischel-Ghodsian N, Koeffler HP. Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood 2000, 95(4):1451-1455.
11. Matzner Y, Abedat S, Shapiro E, Eisenberg S, Bar-Gil-Shitrit A, Stepensky P, Calco S, Azar Y, Urieli-Shoval S. Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures. Blood 2000, 96(2):727-731.
12. Papin S, Duquesnoy P, Cazeneuve C, Pantel J, Coppey-Moisan M, Dargemont C, Amselem S. Alternative splicing at the MEFV locus involved in familial Mediterranean fever regulates translocation of the marenostrin/pyrin protein to the nucleus. Hum Mol Genet 2000, 9(20):3001-3009. 10.1093/hmg/9.20.3001, 11115844.
13. Diaz A, Hu C, Kastner DL, Schaner P, Reginato AM, Richards N, Gumucio DL. Lipopolysaccharide-induced expression of multiple alternatively spliced MEFV transcripts in human synovial fibroblasts: a prominent splice isoform lacks the C-terminal domain that is highly mutated in familial Mediterranean fever. Arthritis Rheum 2004, 50(11):3679-3689. 10.1002/art.20600, 15529356.
14. Medlej-Hashim M, Serre JL, Corbani S, Saab O, Jalkh N, Delague V, Chouery E, Salem N, Loiselet J, Lefranc G, Mégarbané A. Familial Mediterranean fever (FMF) in Lebanon and Jordan: a population genetics study and report of three novel mutations. Eur J Med Genet 2005, 48:412-420. 10.1016/j.ejmg.2005.05.010, 16378925.
15. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997, 40(10):1879-1885. 10.1002/art.1780401023, 9336425.
16. Hennekam RC. Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A 2006, 140(23):2603-2624.
17. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 2003, 31(13):3568-3571. 10.1093/nar/gkg616, 169022, 12824367.
18. Notarnicola C, Didelot MN, Kone-Paut I, Seguret F, Demaille J, Touitou I. Reduced MEFV messenger RNA expression in patients with familial Mediterranean fever. Arthritis Rheum 2002, 46(10):2785-2793. 10.1002/art.10575, 12384939.
19. Ustek D, Ekmekci CG, Selçukbiricik F, Cakiris A, Oku B, Vural B, Yanar H, Taviloglu K, Ozbek U, Gül A. Association between reduced levels of MEFV messenger RNA in peripheral blood leukocytes and acute inflammation. Arthritis Rheum 2007, 56(1):345-350. 10.1002/art.22320, 17195238.
20. Booty MG, Chae JJ, Masters SL, Remmers EF, Barham B, Le JM, Barron KS, Holland SM, Kastner DL, Aksentijevich I. Familial Mediterranean fever with a single MEFV mutation: Where is the second hit?. Arthritis Rheum 2009, 60(6):1851-1861. 10.1002/art.24569, 2753538, 19479870.
21. Jaresova I, Rozkova D, Spísek R, Janda A, Brazova J, Sediva A. Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis. Microbes Infect 2007, 9(11):1359-1367. 10.1016/j.micinf.2007.06.009, 17890129.